Increase expiratory strength with SpiroGym
- Trial ID
- NCT06942533
- Official Title
- The Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease
- Goal
- Increase expiratory strength with SpiroGym
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- General University Hospital, Prague
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson Disease, Breathing Exercises, Telemedicine
- Interventions
- EMST with SpiroGym app, EMST without SpiroGym app
Summary For Families
The goal is to see whether visual feedback from the SpiroGym mobile app helps people with Parkinson's get more out of expiratory muscle strength training, which aims to strengthen the muscles used for coughing and protecting the airway. Participants perform EMST, which makes you exhale against a calibrated resistance to build expiratory muscle power, and the study compares doing EMST with real-time visual cues from the app versus EMST without the app to see if feedback improves technique or performance. The trial is enrolling men and women aged 40 to 80 with Parkinson's who have been on a stable dopaminergic medication dose for at least one month, excluding those with other neurological disorders, major cognitive or psychiatric issues, prior head or neck cancer or surgery, or any acute illness during the study.
Locations
- General University Hospital, Prague, Czechia
- Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
Frequently Asked Questions
- What is this trial testing?
- This trial is studying EMST with SpiroGym app. The goal is to see whether visual feedback from the SpiroGym mobile app helps people with Parkinson's get more out of expiratory muscle strength training, which aims to strengthen the muscles used for coughing and protecting the airway. Participants perform EMST, which makes you exhale against a calibrated resistance to build expiratory muscle power, and the study compares doing EMST with real-time visual cues from the app versus EMST without the app to see if feedback improves technique or performance. The trial is enrolling men and women aged 40 to 80 with Parkinson's who have been on a stable dopaminergic medication dose for at least one month, excluding those with other neurological disorders, major cognitive or psychiatric issues, prior head or neck cancer or surgery, or any acute illness during the study.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.